Nexalin Technology CEO Mark White Issues Letter to Shareholders Highlighting Recent Achievements and Outlook for 2025

DIFS Technology: A Potential Game-Changer for Mental Health Treatments Setting New Benchmarks: 65% Response Rate Shown in Completed Depression Trials Alzheimer’s Research Shows Promising Results with Increased Brain Activity Virtual Clinic Poised to Revolutionize Mental Health Care with AI Integration Pursuing CE Mark to Expand into European Markets in 2025 Strategic Focus on PTSD, TBI, and Addiction Research for Veterans Global Growth with Approvals in China, Brazil, and Oman Neuromodulation Market Positi ...